Powder represents 74.0% of the form category and ≥99.5% accounts for 64.0% of purity grade demand in 2026. The ezetimibe market is estimated at USD 19.7 million in 2026, is projected to reach USD 33.4 million by 2036 and is forecast to post a 5.4% CAGR between 2026 and 2036.